Progress in Cardiac Resynchronisation Therapy and Optimisation

Author:

Akhtar Zaki1,Gallagher Mark M.1ORCID,Kontogiannis Christos1,Leung Lisa W. M.1,Spartalis Michael2ORCID,Jouhra Fadi1,Sohal Manav1,Shanmugam Nesan1

Affiliation:

1. Department of Cardiology, St George’s University Hospital, Blackshaw Road, London SW17 0QT, UK

2. Department of Cardiology, National and Kapodistrian University of Athens, 10679 Athens, Greece

Abstract

Cardiac resynchronisation therapy (CRT) has become the cornerstone of heart failure (HF) treatment. Despite the obvious benefit from this therapy, an estimated 30% of CRT patients do not respond (“non-responders”). The cause of “non-response” is multi-factorial and includes suboptimal device settings. To optimise CRT settings, echocardiography has been considered the gold standard but has limitations: it is user dependent and consumes time and resources. CRT proprietary algorithms have been developed to perform device optimisation efficiently and with limited resources. In this review, we discuss CRT optimisation including the various adopted proprietary algorithms and conduction system pacing.

Funder

Abbott Medical

Publisher

MDPI AG

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Reference91 articles.

1. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: Population based cohort study;Taylor;BMJ,2019

2. National Institute for Cardiovascular Outcomes Research (NICOR), Institute of Cardiovascular Science, and University College London (2021, January 23). National Heart Failure Audit Summary Report 2019. Available online: https://www.nicor.org.uk/wp-content/uploads/2019/09/Heart-Failure-2019-Report-final.pdf.

3. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction;McMurray;N. Engl. J. Med.,2019

4. The Consensus Trial Study Group (1987). Effects of Enalapril on Mortality in Severe Congestive Heart Failure. N. Engl. J. Med., 316, 1429–1435.

5. The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure;Packer;N. Engl. J. Med.,1996

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3